MOSCOW (MRC) -- Melitek, the Danish compounder celebrated the finishing of its expansion project and the start-up of a new production line on 15 September, as per GV.
During the last year, the company headquartered in Alslev, expanded its plant with new buildings for additional production area and an extra warehouse.
"The expansion has proceeded according to plan and budget and the new production line is installed and ready for start-up in October 2014," says Kim Laursen, Managing Director.
"The new line is in essence a true duplicate of our current line with same brands and sizing making it redundant to our current large medical line. It will however have many new features making production even more efficient and safe so indeed we are looking forward to take it into use," continues Kim Laursen.
The company said, that is experiencing increased sale from existing customers as well as from new customers. "We are expecting continued growth from our current customers and we also enjoy start of supply to new customers that will yield a strong demand for our products and services dedicated to the healthcare segment. Our growth is both on our elastomer for PVC replacement and on modified polymer plus systems," informs Jesper Laursen, Melitek’s Business Director.
With the new line in operation, Melitek has three lines dedicated to meliflex compounds for healthcare market yielding a total capacity of 25 000 tonne. The company expects that the turnover, due to the additional production line, will double within the next 5 years.
As MRC reported earlier, the value of the global medical polymer market is set to rise by more than half in the next five years, boosted by an ageing population and developing markets. The market is estimated to grow from USUSD2.3 bln to over USUSD3.5 bln, a rise of more than 52%, between now and 2018.
Melitek is a private owned Danish company specialised in medical compounds based on 30 years of experience servicing the healthcare market. Under the brand name Meliflex the company offers a broad range of materials (PE, PP, TPE, TPO and COC based compounds) that are produced according to GMP and ISO with an extensive medical service package. The compounds are PVC-free and do not contain any phthalate plasticizers.
MRC